Disodium 4,5-dihydro-4,5-dioxo-1H-pyrrolo(2,3-f)quinoline-2,7,9-tricarboxylate:Exports & Compliance White Paper 2026

I. Executive Summary

Pyrroloquinoline quinone disodium salt (PQQ-Na2, CAS 122628-50-6, C14H4N2Na2O8, molecular weight 374.17) is a tricyclic orthoquinone supplied as a red-brown to orange crystalline powder for dietary supplement, food and cosmetic channels. It is the disodium salt of a redox-active quinone cofactor produced either by bacterial fermentation or by chemical synthesis. It is water soluble, strongly hygroscopic and light sensitive, and those three properties drive every decision about analysis, packaging and shelf life.

This document makes no health, mitochondrial, cognitive, longevity or disease claims for this substance. It is written for professional buyers assessing specification, process route, regulatory status and supply logistics. Responsibility for the compliance of any claim made on a finished retail product rests entirely with the brand owner placing that product on the market, who must hold substantiation appropriate to the jurisdiction and respect the conditions of any authorisation.

The commercially decisive issues are specification and status. Assay by high-performance liquid chromatography, related quinones and degradation products, water content, sodium stoichiometry, heavy metals, residual solvents and microbial limits define whether a lot is food-grade, and the route of manufacture determines which of those is hardest to control. On status, the European Union has authorised the substance as a novel food under Regulation (EU) 2015/2283 subject to defined conditions of use, while the United States operates through the Dietary Supplement Health and Education Act framework with new dietary ingredient notification considerations.

II. Product Deep Dive: Molecular Mechanisms and Production Evolution

2.1 Physicochemical Properties and Mechanisms

The molecule combines a pyrroloquinoline tricyclic system with an orthoquinone and two carboxylic acid functions present as sodium salts. The quinone is a reversible two-electron redox system, which makes the substance analytically distinctive and also unstable: quinones are readily reduced and the reduced forms reoxidise and rearrange, so colour is an indicator of chemical history rather than a cosmetic attribute.

• Hygroscopicity, Light Sensitivity and Colour Stability: The disodium salt takes up water readily, so water content and assay-on-dry-basis must be measured together, and loss on drying alone is not an acceptable substitute for Karl Fischer titration. Light exposure drives degradation and colour drift, so manufacture, sampling and packaging run under controlled light and the powder is packed in amber primary packaging. Buyers should treat colour and water drift on arrival as release criteria, not as observations.
• Sodium Stoichiometry and Counter-Ion Control: The declared substance is the disodium salt, so sodium content is part of identity rather than an impurity. Incomplete salt formation or mixed acid and salt forms shift solubility and the calculated assay, and excess inorganic sodium from neutralisation inflates residue on ignition. Buyers should require sodium content by inductively coupled plasma or atomic absorption alongside the chromatographic assay so that the salt form, not merely the chromophore, is confirmed.

2.2 Synthesis and Manufacturing Technologies

Two manufacturing routes supply the market and they produce recognisably different impurity profiles, which is why buyers ask about route even when the specification looks identical. Fermentation gives material that can be described as nature-identical and carries biological residues; chemical synthesis gives tighter control of biological parameters but a different set of inorganic and solvent-related concerns.

• Fermentation Route and Its Impurity Profile: Production uses bacterial fermentation, including methylotrophic and hybrid strains, in fed-batch culture, followed by cell separation, capture on ion-exchange or adsorptive resin, concentration and crystallisation of the sodium salt. The impurities buyers must manage are residual biomass, protein and deoxyribonucleic acid from the production organism, endotoxin, medium components and co-pigments. Fermentation-derived material supports a nature-identical description, but that description must be substantiated and does not exempt the material from endotoxin and microbial limits.
• Chemical Synthesis Route and Its Impurity Profile: Multi-step chemical construction of the pyrroloquinoline skeleton followed by oxidation to the quinone and salt formation is the alternative. Its characteristic risks are heavy metal residues from catalytic steps, residual solvents, regioisomeric and related quinone by-products, and inorganic salt load. Buyers should apply residual solvent limits consistent with ICH Q3C class thinking and heavy metal limits expressed as lead, cadmium, mercury and arsenic, and should require the declared route on the certificate of analysis.

2.3 Core Application Matrix

• Dietary Supplement and Food Ingredient Channels: The substance is supplied to supplement and food manufacturers for use in capsules, tablets, powders and, where authorised, beverages and foods. Use is permitted only within the conditions of the applicable authorisation, including the population addressed and any maximum daily intake, and any representation on the finished label is the responsibility of the brand owner.
• Cosmetic and Personal-Care Formulation: The quinone redox chemistry makes the substance attractive as a cosmetic ingredient, handled under cosmetic product safety assessment and labelling rules with the same claims boundary: the ingredient supplier provides specification and safety data for the raw material, while claims compliance and product safety assessment belong to the responsible person placing the cosmetic on the market.
• Analytical Reference and Research Supply: Characterised lots are supplied as analytical reference standards and for research use, where the purchase driver is certified assay, full impurity profiling and documented traceability rather than volume. Material for research use is not a finished consumer product and carries no implication of suitability for any finished application.

III. Global Market Supply-Demand Landscape and Export Trends

3.1 Demand Drivers and Market Shifts

Demand is driven by the dietary supplement category and by the regulatory gateways that open or close individual markets, rather than by industrial consumption. Each new authorisation or clarification of conditions of use creates a discrete step change in addressable volume, and each enforcement action against finished products making impermissible claims produces a corresponding tightening of buyer due diligence. Brand owners increasingly demand route transparency and third-party testing before qualifying a source.

3.2 Capacity Distribution and Export Flows

Production capability is concentrated in three places. China hosts fermentation and synthetic capacity at commercial scale and supplies most exported bulk material. Japan has long-standing fermentation research and production heritage for this cofactor and supplies high-specification and branded material. The United States and Europe hold formulation, encapsulation and brand channels plus analytical and certification infrastructure, importing bulk active and adding specification, testing, documentation and finished format. Trade therefore flows from Asian production to western finishing, with specification grade setting the premium direction.

3.3 Market Bifurcation and Pricing Dynamics

The market is sharply bifurcated by documentation. Bulk active sold on assay alone competes aggressively on price and is sensitive to fermentation scale-up and to solvent and energy costs. Material sold with a fully documented dossier, covering route, impurity profile, heavy metals, residual solvents, microbial limits, third-party ISO 17025 verification and food-safety certification under ISO 22000 or FSSC 22000, commands a substantial premium and is contracted on annual technical agreements. Because requalifying a formulation against a new source requires stability and analytical work, specification-grade pricing is inelastic relative to bulk spot.

IV. In-depth Analysis of Global Compliance and Regulatory Barriers

This substance cannot be sold on specification alone. It sits inside food law in every market, and the permission to use it, the conditions attached to that permission and the claims regime applying to finished products are three separate questions. No claim of any physiological or health benefit is made or implied in this document.

4.1 European Market: Novel Food Authorisation and Food Supplement Rules

• Novel Food Authorisation under Regulation (EU) 2015/2283: Pyrroloquinoline quinone disodium salt was assessed and authorised as a novel food under Regulation (EU) 2015/2283, with the authorisation published in the Union list together with the specified conditions of use, the population for which it is authorised and any labelling requirements that apply. Buyers must read those conditions directly and comply with them, because the authorisation is use-specific: it does not permit use in every food category or transfer to other salt forms.
• Food Supplements under Directive 2002/46/EC and Regulation 1170/2009: Where the substance is used in food supplements, Directive 2002/46/EC and Regulation (EC) No 1170/2009, which sets the list of permitted vitamin and mineral substances and their forms, apply alongside the novel food conditions. The finished supplement must meet the compositional and labelling rules of the member state where it is placed on the market, and responsibility for that compliance and for any claim on the label rests with the food business operator.

4.2 North American and Asia-Pacific Regulatory Positions

• United States: DSHEA, New Dietary Ingredient Notification and Enforcement: In the United States the substance is treated under the Dietary Supplement Health and Education Act framework, and a new dietary ingredient notification with safety information is the mechanism by which an ingredient not marketed before the statutory cut-off enters the market. The Food and Drug Administration has an established enforcement history against finished supplements making disease claims, which is why buyers should require specification and safety documentation from suppliers but never claims support, keeping responsibility for claims with their own regulatory function.
• Canada, Australia and New Zealand, and China: In Canada a finished natural health product requires a licence and product number before sale, and the ingredient must be acceptable under the applicable framework. In Australia and New Zealand, Food Standards Australia New Zealand treats the substance as requiring pre-market assessment before use in food. In China, the substance is addressed through the new food ingredient and health food routes administered by the national health and market regulation authorities, and current listing status and scope must be verified before any placement.

4.3 The Critical Hurdle: Quality Control and Safety Limits

V. Green Trade Barriers and ESG in Manufacturing

Because this is a food-chain ingredient, environmental scrutiny is inseparable from food-safety scrutiny. Buyers audit the site as a food ingredient manufacturer first and as a chemical manufacturer second, so certification, hygiene zoning and water quality matter as much as yield and solvent recovery.

5.1 Carbon Footprint and Circular Economy

The footprint profile differs by route. Fermentation consumes sterilisation steam, aeration power and a carbon substrate, then a largely aqueous downstream train with significant water use; chemical synthesis consumes solvents and energy across several steps with a higher solvent recovery burden. Buyers should request cradle-to-gate figures with a stated allocation rule, the renewable electricity share, and solvent recovery and water recycling rates, together with ISO 14001 evidence, and should note that downstream purification usually dominates the utility load.

5.2 Sustainable Sourcing, Certification and Traceability

Food-safety certification is the practical entry ticket: ISO 22000 or FSSC 22000 certification, a documented hazard analysis and critical control point plan, and third-party testing by ISO 17025 accredited laboratories are what brand owners ask for. Buyers also routinely require halal, kosher and vegan certification, non-GMO status for the fermentation substrate and production organism, and a statement on whether the production strain is genetically modified, since that determines labelling and market access. Traceability should run from the strain and substrate through to the finished lot with retained samples.

VI. Supply Chain Resilience and Export Logistics

Logistics for this substance are governed by stability rather than by hazard. It is not a dangerous good in the conventional sense for most dossiers, but it is hygroscopic, light sensitive and thermally sensitive, so the chain is designed to exclude moisture and light and hold a defined temperature range to formulation.

6.1 Packaging Standards and Moisture/Contamination Control

• Amber Light-Protective Primary Packaging with Desiccant: Standard presentation is a double polyethylene bag inside an amber or opaque barrier container, typically a high-density polyethylene drum or an aluminium composite can, with pharmaceutical-grade desiccant and a moisture-barrier seal. Headspace should be minimised and filled under dry nitrogen where the process allows. Buyers should require a documented seal integrity check and reject outer packaging opened or resealed in transit.
• Cold and Dry Chain with Controlled Sampling: Material is stored and shipped under controlled temperature, commonly refrigerated for long-duration or hot-climate routes, with temperature logging and defined excursion handling. Because opening a container exposes the contents to humidity, sampling must be done in a low-humidity environment with immediate resealing, and retained samples stored under the same conditions as the bulk. Water content must be retested after any opening.

6.2 Dangerous Goods Identification and Transit Protocols

Consignments are normally shipped as non-dangerous goods for road, sea and air, with the classification confirmed from the supplier safety data sheet and the residual risk being degradation rather than acute hazard. The operational requirements are therefore different from a hazmat shipment: temperature-controlled packaging with continuous recording and defined excursion limits, desiccant and moisture-barrier integrity checks, protection from light, and customs and food-import documentation held with the shipment. Buyers should require a certificate of analysis linked to the specific lot and packing date, retained samples and a defined protocol for handling temperature excursions before accepting a delivery.

VII. Enterprise Global Expansion Strategy Guide

Suppliers win here by de-risking the buyer's regulatory position rather than by competing on assay alone. Three moves matter most.

1. Declare the Route and Own the Impurity Profile: State whether material is fermentation-derived or chemically synthesised, and publish the impurity set that follows, including endotoxin and residual biomass for fermentation and heavy metals and residual solvents for synthesis. Provide USP or FCC grade options where applicable and supply ISO 17025 accredited third-party verification.
2. Separate Compliance from Claims, Explicitly: Provide regulatory status summaries covering the novel food authorisation and its conditions, the food supplement framework, the new dietary ingredient position and the Canadian, Australian, New Zealand and Chinese positions, and state in writing that no health or disease claim is made or supported by the supplier. Buyers value that boundary because it protects their label review.
3. Engineer Stability Into the Pack: Invest in amber barrier packaging, desiccant, nitrogen filling, cold chain and light-controlled handling, publish stability data generated under the intended storage condition, and offer certification packages including halal, kosher, vegan and non-GMO status. Sports nutrition customers additionally require anti-doping screening documentation from recognised programmes.

VIII. Conclusion

Pyrroloquinoline quinone disodium salt is a specification-driven food-chain ingredient whose commercial value depends less on bulk chemistry than on documentation, stability engineering and regulatory clarity. The route of manufacture sets the impurity profile, the salt form sets the identity, and hygroscopicity and light sensitivity set the shelf life, so a supplier who controls all three is selling certainty rather than powder.

No health, mitochondrial, cognitive, longevity or disease claim is made in this document. Market access in the European Union runs through the novel food authorisation and its specific conditions of use, in the United States through the dietary supplement framework with new dietary ingredient considerations, and elsewhere through national assessments that must be verified case by case. Buyers who hold suppliers to route transparency, ISO 17025 verified specifications and real stability data will be the ones whose finished products survive label review and enforcement scrutiny.

IX. Industry Resource Connection and Supplier Ecosystem

Powered by Guidechem

This white paper is exclusively compiled by the Guidechem Intelligence Team based on global customs data, regulatory databases, and industry research. Guidechem is a leading global B2B chemical platform, dedicated to connecting global buyers with verified, high-quality manufacturers.

Guidechem Global Pyrroloquinoline quinone disodium salt Supplier Ecosystem List

Relying on Guidechem's extensive global database, we have mapped the core participants in the current global Pyrroloquinoline quinone disodium salt supply chain:

• China Fermentation and Synthetic Production Ecosystem: Chinese producers operate both bacterial fermentation and chemical synthesis routes at commercial scale, supplying most exported bulk active and increasingly offering food-safety certification, ISO 17025 testing and documented impurity profiles. The ecosystem competes on scale and cost and is moving up the specification curve.
• Japan Fermentation Heritage Ecosystem: Japanese producers hold long-standing research and production experience with this redox cofactor, supplying high-specification and branded material with strong stability data and conservative documentation. Their grades are frequently the reference against which other sources are benchmarked.
• United States and European Finishing Ecosystem: United States and European operators import bulk active and add formulation, encapsulation, third-party testing, certification and documentation, holding ISO 22000 or FSSC 22000 certification and the novel food and dietary supplement expertise that brand customers require. They compete on specification, testing and regulatory support rather than on bulk price.